Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Judy E. Garber, MD, MPH


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Chief, Division for Cancer Genetics and Prevention
  • Susan F. Smith Chair
  • Institute Physician
  • Professor of Medicine, Harvard Medical School

Clinical Interests

  • Breast cancer
  • Cancer genetics
  • Cancer prevention

Diseases Treated

Contact Information

  • Appointments617-632-2178 (Cancer Genetics and Prevention)
    617-582-7777 (established patients CGP)
    617-632-2175 (Breast Oncology)
    617-632-3800 (established patients BO)
  • Fax617-582-8807

Bio

Dr. Garber is the Chief of the Division for Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. She also consults with the Pediatric Cancer Genetic Risk Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dr. Garber conducts research in clinical cancer genetics, with a special focus in the genetics of breast cancer. She has played a major role in the development of national guidelines in cancer genetics. She is also a leader in research into the characteristics and treatment of triple negative or basal-like breast cancer, the most common form in women with BRCA1 mutations. Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers.Dr. Garber is a past president and current member of the Foundation Board of the American Association for Cancer Research (AACR). She serves on the National Cancer Advisory Board of the National Cancer Institute and was elected into the National Academy of Medicine in 2013. She also serves as the Chair of the Breast Cancer Research Foundation (BCRF) Scientific Advisory Board. She is an ASCO Statesman and a Fellow of the AACR Academy.

Board Certification:

  • Hematology, 1988
  • Internal Medicine, 1984
  • Medical Oncology, 1987

Fellowship:

  • Brigham and Women's Hospital, Hematology
  • Dana-Farber Cancer Institute, Cancer Epidemiology
  • Dana-Farber Cancer Institute, Medical Oncology

Residency:

  • Brigham and Women's Hospital, Internal Medicine

Medical School:

  • Yale University School of Medicine

Recent Awards:

  • Charles H. Dyson Scholar in Clinical Research, DFCI 1997
  • Tisch Award, Dana-Farber Cancer Institute, 2007
  • ASCO Statesman Award, American Society of Clinical Oncology, 2008
  • Claire W. and Richard P. Morse Research Award, Dana-Farber Cancer Institute, 2009
  • Fellow, AACR Academy, American Association for Cancer Research, 2013
  • Member, Institute of Medicine/National Academy of Medicine, 2014
  • Margaret L. Kripke Legend Award, MD Anderson Cancer Center, 2017
  • AACR Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research, 2017
  • Umberto Veronesi IEO Breast Cancer Award, 2017

Research

Clinical Cancer Genetics, Cancer Risk, and Prevention

Our group has two areas of active interest: the identification of individuals with genetic factors that place them at high risk of developing cancer, and the development of strategies to reduce cancer risk. We focus on breast cancer primarily, but are now expanding our efforts to other cancers. Breast cancer geneticsOur group developed one of the first cancer risk and prevention clinics, where we recruit patients and families with hereditary and familial breast cancer, evaluate them for mutations in BRCA1, BRCA2, and other genes, and then enroll patients in ongoing follow-up studies. These studies evaluate the long-term psychosocial and medical effects of genetic testing and explore the best ways to integrate genetic testing into the care of women diagnosed with breast cancer. We are also studying the prevalence of germline p53 mutations and mutations in the Fanconi anemia (FA) genes in a cohort of the very youngest women diagnosed with breast cancer. In collaboration with Dr. Alan D'Andrea, we also plan to expand epidemiologic studies of the FA genes to squamous tumors. Breast cancer risk reductionWe are developing novel approaches to the chemoprevention of cancer and the identification of modulatable biomarkers for use in chemoprevention studies. One clinical trial uses aromatase inhibitors to reduce circulating estradiol in women who have the highest levels, and measures changes in bone density and mammographic breast density as biomarkers of hormone effect. Another trial is piloting tamoxifen in women with increased risk of breast cancer because of chest radiation therapy for Hodgkin's disease. In collaboration with Drs. Myles Brown and Bruce Spiegelman, we are developing biomarker assays for use in the evaluation of rosiglitazone in an early-phase breast cancer chemoprevention trial. In a phase I chemoprevention trial, we are studying the epidermal growth factor receptor (EGFR) antagonist, Iressa. Finally, we are developing duct lavage as a sampling technique with which to identify modulatable biomarkers for use in breast cancer chemoprevention trials.PharmacogeneticsWe are also interested in using genetic markers to identify individuals at particular risk for toxic side effects of chemoprevention agents. Two large national trials are evaluating the potential contributions of hereditary clotting abnormalities, factor V Leiden and prothrombin G20210A, to the risk of thromboembolic complications with tamoxifen.

Does Quantitative Sensory Testing Improve Prediction of Chronic Pain Trajectories? A Longitudinal Study of Youth with Functional Abdominal Pain Participating in a Randomized Controlled Trial of Cognitive Behavioral Treatment. Clin J Pain. 2021 Jun 30.
View in: PubMed

Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study. J Gen Intern Med. 2021 Jun 25.
View in: PubMed

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genet Med. 2021 Jun 10.
View in: PubMed

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. N Engl J Med. 2021 06 24; 384(25):2394-2405.
View in: PubMed

The clinical and functional effects of TERT variants in myelodysplastic syndrome. Blood. 2021 May 21.
View in: PubMed

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14; 12(1):2986.
View in: PubMed

The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial. Cancer Prev Res (Phila). 2021 Jul; 14(7):753-762.
View in: PubMed

Trans-ethnic variation in germline variants of patients with renal cell carcinoma. Cell Rep. 2021 Mar 30; 34(13):108926.
View in: PubMed

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 02 17; 12(1):1078.
View in: PubMed

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing. JCO Precis Oncol. 2021; 5.
View in: PubMed

Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid Carcinoma. Am J Case Rep. 2020 Dec 27; 21:e927415.
View in: PubMed

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer. Nat Cancer. 2021 Jan; 2(1):66-82.
View in: PubMed

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D. J Natl Cancer Inst. 2020 12 14; 112(12):1242-1250.
View in: PubMed

Novel Pathogenic Germline Variant of the Adenomatous Polyposis Coli (APC) Gene, p.S2627Gfs*12 Identified in a Mild Phenotype of APC-Associated Polyposis: A Case Report. Am J Case Rep. 2020 Dec 11; 21:e927293.
View in: PubMed

A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer. Clin Cancer Res. 2021 Feb 15; 27(4):967-974.
View in: PubMed

Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer. Gynecol Oncol. 2021 02; 160(2):457-463.
View in: PubMed

Personalized Depression Prevention: A Randomized Controlled Trial to Optimize Effects Through Risk-Informed Personalization. J Am Acad Child Adolesc Psychiatry. 2020 Nov 13.
View in: PubMed

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. J Clin Oncol. 2020 12 20; 38(36):4274-4282.
View in: PubMed

'Case of the Month' from Brigham and Women's Hospital, Boston, MA, USA: a 70-year-old man with lung cysts and bilateral renal masses. BJU Int. 2020 10; 126(4):428-432.
View in: PubMed

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer. NPJ Breast Cancer. 2020; 6:44.
View in: PubMed

Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations. J Genet Couns. 2021 Feb; 30(1):268-282.
View in: PubMed

Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers. JCO Precis Oncol. 2020; 4.
View in: PubMed

A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome. Genome Res. 2020 08; 30(8):1170-1180.
View in: PubMed

Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial. BMC Med Res Methodol. 2020 08 17; 20(1):210.
View in: PubMed

Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer. Breast J. 2020 08; 26(8):1528-1534.
View in: PubMed

A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers. Cancer Res. 2020 09 01; 80(17):3732-3744.
View in: PubMed

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med. 2020 10; 22(10):1653-1666.
View in: PubMed

Effects of an adolescent depression prevention program on maternal criticisms and positive remarks. J Fam Psychol. 2020 Dec; 34(8):927-937.
View in: PubMed

Histopathologic features of breast cancer in Li-Fraumeni syndrome. Mod Pathol. 2021 03; 34(3):542-548.
View in: PubMed

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes. JAMA Netw Open. 2020 07 01; 3(7):e208501.
View in: PubMed

Comorbid Sleep Disturbance in Adolescents with Functional Abdominal Pain. Behav Sleep Med. 2021 Jul-Aug; 19(4):471-480.
View in: PubMed

Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines. Hum Mutat. 2020 09; 41(9):1555-1562.
View in: PubMed

Reply to S. Takamizawa et al. J Clin Oncol. 2020 08 10; 38(23):2700-2701.
View in: PubMed

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk. JCO Precis Oncol. 2020; 4.
View in: PubMed

Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ Breast Cancer. 2020 Jun 05; 6(1):19.
View in: PubMed

Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ Breast Cancer. 2020; 6:19.
View in: PubMed

E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells. J Cell Biol. 2020 06 01; 219(6).
View in: PubMed

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020 06; 52(6):572-581.
View in: PubMed

Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer. Cancer Prev Res (Phila). 2020 07; 13(7):623-634.
View in: PubMed

Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II. Cancer Epidemiol Biomarkers Prev. 2020 06; 29(6):1264-1270.
View in: PubMed

Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat Commun. 2020 04 06; 11(1):1711.
View in: PubMed

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw. 2020 04; 18(4):380-391.
View in: PubMed

Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition. Cancer Epidemiol Biomarkers Prev. 2020 05; 29(5):927-935.
View in: PubMed

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genet Epidemiol. 2020 07; 44(5):442-468.
View in: PubMed

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial). J Clin Oncol. 2020 05 10; 38(14):1539-1548.
View in: PubMed

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nat Genet. 2020 01; 52(1):56-73.
View in: PubMed

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma. Genet Med. 2020 04; 22(4):709-718.
View in: PubMed

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. J Clin Oncol. 2020 03 01; 38(7):674-685.
View in: PubMed

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. Clin Cancer Res. 2020 06 01; 26(11):2704-2710.
View in: PubMed

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer. 2019; 5:38.
View in: PubMed

Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer. 2020 01 15; 126(2):271-280.
View in: PubMed

One step forward, two steps backward. Genet Med. 2020 02; 22(2):441-442.
View in: PubMed

Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 Sep 23; 10(1):4386.
View in: PubMed

Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis. Breast Cancer Res. 2019 09 18; 21(1):107.
View in: PubMed

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. Nat Commun. 2019 09 13; 10(1):4182.
View in: PubMed

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2019 11 20; 37(33):3152-3165.
View in: PubMed

Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties. Breast Cancer Res Treat. 2019 Oct; 177(3):741-748.
View in: PubMed

BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry. Hum Mutat. 2019 10; 40(10):1781-1796.
View in: PubMed

Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations. Breast J. 2019 07; 25(4):575-577.
View in: PubMed

Genetic Testing for Breast Cancer Susceptibility Should Be Offered before Unilateral Abdominally Based Free Flap Breast Reconstruction. Plast Reconstr Surg. 2019 07; 144(1):12-20.
View in: PubMed

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2019 07; 121(2):180-192.
View in: PubMed

Genotype-phenotype associations among panel-based TP53+ subjects. Genet Med. 2019 11; 21(11):2478-2484.
View in: PubMed

Estrogen receptor signaling is reprogrammed during breast tumorigenesis. Proc Natl Acad Sci U S A. 2019 06 04; 116(23):11437-11443.
View in: PubMed

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat Commun. 2019 04 15; 10(1):1741.
View in: PubMed

Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Educ Couns. 2019 08; 102(8):1558-1564.
View in: PubMed

Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2019 04; 34(2):229-233.
View in: PubMed

Prevalence of germline variants in inflammatory breast cancer. Cancer. 2019 07 01; 125(13):2194-2202.
View in: PubMed

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. J Natl Cancer Inst. 2019 04 01; 111(4):350-364.
View in: PubMed

Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing. JCO Precis Oncol. 2019; 3.
View in: PubMed

The effect of content and tone of maternal evaluative feedback on self-cognitions and affect in young children. J Exp Child Psychol. 2019 06; 182:151-165.
View in: PubMed

County-level socioeconomic and crime risk factors for substantiated child abuse and neglect. Child Abuse Negl. 2019 04; 90:127-138.
View in: PubMed

Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 01 25; 10(1):431.
View in: PubMed

Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants. J Genet Couns. 2019 06; 28(3):708-716.
View in: PubMed

Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk? Breast Cancer Res Treat. 2019 May; 175(1):1-4.
View in: PubMed

Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk. Breast Cancer Res Treat. 2019 May; 175(1):229-237.
View in: PubMed

Cost-Effectiveness of Preventing Depression Among At-Risk Youths: Postintervention and 2-Year Follow-Up. Psychiatr Serv. 2019 04 01; 70(4):279-286.
View in: PubMed

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063.
View in: PubMed

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018 12; 14(12):e1007752.
View in: PubMed

Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes. JAMA Surg. 2018 12 01; 153(12):1145-1146.
View in: PubMed

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 11; 16(11):1362-1389.
View in: PubMed

Cognitive and Interpersonal Vulnerabilities to Adolescent Depression: Classification of Risk Profiles for a Personalized Prevention Approach. J Abnorm Child Psychol. 2018 10; 46(7):1521-1533.
View in: PubMed

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2018 Oct 01; 29(10):2153.
View in: PubMed

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy. J Clin Oncol. 2018 11 01; 36(31):3134-3143.
View in: PubMed

Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat. 2019 Jan; 173(1):201-207.
View in: PubMed

Mixing Mutation Location With Carcinogen Exposure: A Recipe for Tissue Specificity in BRCA2-Associated Cancers? J Natl Cancer Inst. 2018 09 01; 110(9):925-926.
View in: PubMed

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. J Natl Cancer Inst. 2018 08 01; 110(8):855-862.
View in: PubMed

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing. J Natl Cancer Inst. 2018 08 01; 110(8):863-870.
View in: PubMed

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res. 2018 09 15; 78(18):5419-5430.
View in: PubMed

Precision Prevention and Early Detection of Cancer: Fundamental Principles. Cancer Discov. 2018 07; 8(7):803-811.
View in: PubMed

BRCA1/2 testing: therapeutic implications for breast cancer management. Br J Cancer. 2018 07; 119(2):141-152.
View in: PubMed

Validating parent and child forms of the Parent Perception Inventory. Psychol Assess. 2018 08; 30(8):1065-1081.
View in: PubMed

Towards Prevention of Breast Cancer: What Are the Clinical Challenges? Cancer Prev Res (Phila). 2018 05; 11(5):255-264.
View in: PubMed

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. Ann Oncol. 2018 04 01; 29(4):903-909.
View in: PubMed

Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res. 2018 05 15; 78(10):2747-2759.
View in: PubMed

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat. 2018 05; 39(5):593-620.
View in: PubMed

A counseling framework for moderate-penetrance colorectal cancer susceptibility genes. Genet Med. 2018 11; 20(11):1324-1327.
View in: PubMed

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease. Cancer Prev Res (Phila). 2018 04; 11(4):203-214.
View in: PubMed

Prevention of Depression in At-Risk Adolescents: Moderators of Long-term Response. Prev Sci. 2018 02; 19(Suppl 1):6-15.
View in: PubMed

Social learning pathways in the relation between parental chronic pain and daily pain severity and functional impairment in adolescents with functional abdominal pain. Pain. 2018 02; 159(2):298-305.
View in: PubMed

Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus. 2018 Feb 01; 31(2).
View in: PubMed

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Ann Oncol. 2018 01 01; 29(1):281-282.
View in: PubMed

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study. Ann Oncol. 2018 01 01; 29(1):154-161.
View in: PubMed

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. JAMA Oncol. 2017 12 01; 3(12):1634-1639.
View in: PubMed

A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings. J Community Genet. 2018 Jul; 9(3):233-241.
View in: PubMed

Judy Garber on PARP Inhibitors for Triple-Negative Breast Cancer. Oncology (Williston Park). 2017 11 15; 31(11):814-5, 835.
View in: PubMed

Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017; 3:44.
View in: PubMed

Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. Pediatr Blood Cancer. 2018 Feb; 65(2).
View in: PubMed

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet. 2017 Dec; 49(12):1767-1778.
View in: PubMed

Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients. Clin Cancer Res. 2017 Dec 01; 23(23):7351-7359.
View in: PubMed

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up. JNCI Cancer Spectr. 2017 Sep; 1(1):pkx002.
View in: PubMed

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017 08 01; 28(8):1700-1712.
View in: PubMed

Interacting influences of gender and chronic pain status on parasympathetically mediated heart rate variability in adolescents and young adults. Pain. 2017 08; 158(8):1509-1516.
View in: PubMed

Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers. Am J Surg. 2017 Oct; 214(4):687-694.
View in: PubMed

Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. Cancer Discov. 2017 10; 7(10):1098-1115.
View in: PubMed

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Cancer. 2017 Sep 15; 123(18):3532-3539.
View in: PubMed

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017; 3:22.
View in: PubMed

Reassessing risk models for atypical hyperplasia: age may not matter. Breast Cancer Res Treat. 2017 Sep; 165(2):285-291.
View in: PubMed

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2017 06 01; 23(11):e38-e45.
View in: PubMed

Managing hereditary breast cancer risk in women with and without ovarian cancer. Gynecol Oncol. 2017 07; 146(1):205-214.
View in: PubMed

Precancer Atlas to Drive Precision Prevention Trials. Cancer Res. 2017 04 01; 77(7):1510-1541.
View in: PubMed

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet. 2017 May; 49(5):680-691.
View in: PubMed

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. J Clin Oncol. 2017 Apr 10; 35(11):1179-1188.
View in: PubMed

Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study. Genet Med. 2017 07; 19(7):787-795.
View in: PubMed

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. J Natl Compr Canc Netw. 2017 01; 15(1):9-20.
View in: PubMed

The fuzzy world of precision medicine: deliberations of a precision medicine tumor board. Per Med. 2017 Jan; 14(1):37-50.
View in: PubMed

Community-level moderators of a school-based childhood sexual assault prevention program. Child Abuse Negl. 2017 Jan; 63:295-306.
View in: PubMed

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res. 2016 11 11; 18(1):112.
View in: PubMed

Using machine learning to parse breast pathology reports. Breast Cancer Res Treat. 2017 01; 161(2):203-211.
View in: PubMed

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. JAMA Oncol. 2016 Nov 01; 2(11):1434-1440.
View in: PubMed

Reply to S.M. Sorscher and M.J. Hall et al. J Clin Oncol. 2016 12; 34(34):4187-4188.
View in: PubMed

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Res Treat. 2017 01; 161(1):117-134.
View in: PubMed

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. Future Oncol. 2017 Feb; 13(4):307-320.
View in: PubMed

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat. 2016 12; 160(3):393-410.
View in: PubMed

Treatment and Prevention of Depression and Anxiety in Youth: Test of Cross-Over Effects. Depress Anxiety. 2016 10; 33(10):939-959.
View in: PubMed

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing. J Clin Oncol. 2016 12; 34(34):4071-4078.
View in: PubMed

Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci U S A. 2016 09 27; 113(39):10750-8.
View in: PubMed

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat Commun. 2016 09 07; 7:12675.
View in: PubMed

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS One. 2016; 11(7):e0158801.
View in: PubMed

The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Genome Med. 2016 07 26; 8(1):79.
View in: PubMed

Congruence of Parents' and Children's Perceptions of Parenting: A Meta-Analysis. J Youth Adolesc. 2016 10; 45(10):1973-95.
View in: PubMed

Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data. Am J Hematol Oncol. 2016 Jul; 12(7):4-9.
View in: PubMed

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Res. 2016 06 21; 18(1):64.
View in: PubMed

Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol. 2016 09; 13(9):581-8.
View in: PubMed

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 01; 2(6):730-6.
View in: PubMed

CANCER. The cancer predisposition revolution. Science. 2016 May 27; 352(6289):1052-3.
View in: PubMed

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun. 2016 04 27; 7:11375.
View in: PubMed

Within-Person Changes in Individual Symptoms of Depression Predict Subsequent Depressive Episodes in Adolescents: a Prospective Study. J Abnorm Child Psychol. 2016 Apr; 44(3):483-94.
View in: PubMed

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):13587-98.
View in: PubMed

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol. 2016 May 01; 34(13):1460-8.
View in: PubMed

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2016 08 01; 22(15):3764-73.
View in: PubMed

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet. 2016 Apr; 48(4):374-86.
View in: PubMed

Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer. NPJ Breast Cancer. 2016; 2:16002.
View in: PubMed

The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women. Cancer Prev Res (Phila). 2016 05; 9(5):379-84.
View in: PubMed

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genet Med. 2016 10; 18(10):1011-9.
View in: PubMed

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2016 Feb 09; 18(1):15.
View in: PubMed

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016 02; 14(2):153-62.
View in: PubMed

Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):219-26.
View in: PubMed

THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS. Trans Am Clin Climatol Assoc. 2016; 127:127-139.
View in: PubMed

Statin Use and Breast Cancer Risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):201-6.
View in: PubMed

Transforming Cancer Prevention through Precision Medicine and Immune-oncology. Cancer Prev Res (Phila). 2016 Jan; 9(1):2-10.
View in: PubMed

Developmental Demands of Cognitive Behavioral Therapy for Depression in Children and Adolescents: Cognitive, Social, and Emotional Processes. Annu Rev Clin Psychol. 2016; 12:181-216.
View in: PubMed

Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics. J Clin Oncol. 2016 Feb 20; 34(6):539-41.
View in: PubMed

A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):193-200.
View in: PubMed

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst. 2016 Feb; 108(2).
View in: PubMed

Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years After Implementation Among At-Risk Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Nov; 72(11):1110-8.
View in: PubMed

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling. J Genet Couns. 2016 06; 25(3):472-82.
View in: PubMed

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing? J Clin Oncol. 2015 Oct 01; 33(28):3092-5.
View in: PubMed

PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med. 2015 Aug 13; 13:188.
View in: PubMed

Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Ann Surg Oncol. 2015 Oct; 22(10):3346-9.
View in: PubMed

Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. JAMA. 2015 Jul 14; 314(2):162-9.
View in: PubMed

Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):880-915.
View in: PubMed

Depression history as a moderator of relations between cortisol and shame responses to social-evaluative threat in young adults. Biol Psychol. 2015 Jul; 109:159-65.
View in: PubMed

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol. 2016 05; 141(2):386-401.
View in: PubMed

Programs for the Prevention of Youth Depression: Evaluation of Efficacy, Effectiveness, and Readiness for Dissemination. J Clin Child Adolesc Psychol. 2016 Nov-Dec; 45(6):763-783.
View in: PubMed

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res. 2015 Apr 25; 17:61.
View in: PubMed

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015 Apr 07; 313(13):1347-61.
View in: PubMed

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2015 Jun 10; 33(17):1902-9.
View in: PubMed

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. PLoS One. 2015; 10(4):e0120020.
View in: PubMed

RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest. 2015 Apr; 125(4):1523-32.
View in: PubMed

Longitudinal relations between stress and depressive symptoms in youth: coping as a mediator. J Abnorm Child Psychol. 2015 Feb; 43(2):355-68.
View in: PubMed

Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015 Feb; 47(2):164-71.
View in: PubMed

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2014 Dec 31; 16(6):3416.
View in: PubMed

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res. 2014 Dec 23; 16(6):3419.
View in: PubMed

The effects of psychological treatment of maternal depression on children and parental functioning: a meta-analysis. Eur Child Adolesc Psychiatry. 2015 Feb; 24(2):237-45.
View in: PubMed

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015 Feb 01; 33(4):304-11.
View in: PubMed

BRCA1 haploinsufficiency for replication stress suppression in primary cells. Nat Commun. 2014 Nov 17; 5:5496.
View in: PubMed

Two prospective studies of changes in stress generation across depressive episodes in adolescents and emerging adults. Dev Psychopathol. 2014 Nov; 26(4 Pt 2):1385-400.
View in: PubMed

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):308-16.
View in: PubMed

Trajectories of individual depressive symptoms in adolescents: gender and family relationships as predictors. Dev Psychol. 2014 Dec; 50(12):2633-43.
View in: PubMed

Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. J Sex Med. 2015 Jan; 12(1):189-97.
View in: PubMed

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2014 Nov; 148(2):397-406.
View in: PubMed

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med. 2015 Jun; 17(6):467-75.
View in: PubMed

Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer. 2015 Jan 15; 121(2):286-93.
View in: PubMed

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015 Jan 01; 121(1):25-33.
View in: PubMed

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw. 2014 Sep; 12(9):1326-38.
View in: PubMed

Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children. J Community Genet. 2015 Jan; 6(1):55-62.
View in: PubMed

Executive function moderates the relation between coping and depressive symptoms. Anxiety Stress Coping. 2015; 28(1):31-49.
View in: PubMed

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat. 2014 Jun; 35(6):654-62.
View in: PubMed

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers. Breast Cancer Res Treat. 2014 Jul; 146(1):175-82.
View in: PubMed

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014 Jun; 20(6):682-8.
View in: PubMed

Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology. 2015 Jan; 24(1):33-9.
View in: PubMed

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors. Ann Oncol. 2014 Aug; 25(8):1656-63.
View in: PubMed

Predicting persistence of functional abdominal pain from childhood into young adulthood. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2026-32.
View in: PubMed

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet. 2014 04; 10(4):e1004256.
View in: PubMed

Dysphagia, melanosis, gastrointestinal stromal tumors and a germinal mutation of the KIT gene in an Argentine family. Acta Gastroenterol Latinoam. 2014 Mar; 44(1):9-15.
View in: PubMed

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2. Cancer. 2014 May 15; 120(10):1557-64.
View in: PubMed

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014 Mar 01; 32(7):618-26.
View in: PubMed

Interactive models of depression vulnerability: the role of childhood trauma, dysfunctional attitudes, and coping. Br J Clin Psychol. 2014 Jun; 53(2):245-63.
View in: PubMed

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol. 2014 Feb; 132(2):280-6.
View in: PubMed

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study. Br J Cancer. 2014 Jan 21; 110(2):530-4.
View in: PubMed

Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry. 2013 Nov; 70(11):1161-70.
View in: PubMed

Functional abdominal pain in childhood and long-term vulnerability to anxiety disorders. Pediatrics. 2013 Sep; 132(3):475-82.
View in: PubMed

Dynamic temporal relations between anxious and depressive symptoms across adolescence. Dev Psychopathol. 2013 Aug; 25(3):683-97.
View in: PubMed

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10; 31(23):2942-62.
View in: PubMed

Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiol Biomarkers Prev. 2013 Jul; 22(7):1260-6.
View in: PubMed

Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners. Health Psychol. 2014 Aug; 33(8):765-73.
View in: PubMed

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell. 2013 Jul 03; 13(1):117-30.
View in: PubMed

Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013 Jun 20; 31(18):2282-8.
View in: PubMed

Cortisol reactivity to experimentally manipulated psychosocial stress in young adults at varied risk for depression. Depress Anxiety. 2014 Jan; 31(1):44-52.
View in: PubMed

Prevalence of germline TP53 mutations in HER2+ breast cancer patients. Breast Cancer Res Treat. 2013 May; 139(1):193-8.
View in: PubMed

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr; 45(4):371-84, 384e1-2.
View in: PubMed

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013; 9(3):e1003212.
View in: PubMed

A randomized controlled trial of a cognitive-behavioral program for the prevention of depression in adolescents compared with nonspecific and no-intervention control conditions. J Couns Psychol. 2013 Jul; 60(3):432-8.
View in: PubMed

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol. 2013 Apr 01; 31(10):1267-70.
View in: PubMed

Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry? Psychooncology. 2013 Sep; 22(9):2024-31.
View in: PubMed

Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013 Feb; 52(2):121-31.
View in: PubMed

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012 Dec; 136(3):627-33.
View in: PubMed

Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Couns. 2013 Jun; 22(3):303-14.
View in: PubMed

Frequency of triple-negative breast cancer in BRCA1 mutation carriers: comparison between common Ashkenazi Jewish and other mutations. J Clin Oncol. 2012 Dec 10; 30(35):4447-8.
View in: PubMed

Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers. Am J Surg Pathol. 2012 Oct; 36(10):1483-8.
View in: PubMed

Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet. 2012 Oct; 205(10):479-87.
View in: PubMed

Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol. 2012 Dec; 127(3):544-51.
View in: PubMed

Translating basic psychopathology research to preventive interventions: a tribute to john R. Z. Abela. J Clin Child Adolesc Psychol. 2012; 41(5):666-81.
View in: PubMed

Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators. J Affect Disord. 2012 Dec 20; 143(1-3):223-30.
View in: PubMed

The feasibility of using natural language processing to extract clinical information from breast pathology reports. J Pathol Inform. 2012; 3:23.
View in: PubMed

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21(8):1362-70.
View in: PubMed

Functional abdominal pain patient subtypes in childhood predict functional gastrointestinal disorders with chronic pain and psychiatric comorbidities in adolescence and adulthood. Pain. 2012 Sep; 153(9):1798-1806.
View in: PubMed

Mutational processes molding the genomes of 21 breast cancers. Cell. 2012 May 25; 149(5):979-93.
View in: PubMed

Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov. 2012 Jun; 2(6):503-11.
View in: PubMed

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. Cancer Discov. 2012 Apr; 2(4):366-375.
View in: PubMed

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol. 2012 Apr 20; 30(12):1321-8.
View in: PubMed

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012 Jun; 133(3):1125-30.
View in: PubMed

Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev. 2012 Jun; 32(4):301-15.
View in: PubMed

Sex-specific pathways to early puberty, sexual debut, and sexual risk taking: tests of an integrated evolutionary-developmental model. Dev Psychol. 2012 May; 48(3):687-702.
View in: PubMed

Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival. Cancer Genet. 2012 Jan-Feb; 205(1-2):34-41.
View in: PubMed

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):134-47.
View in: PubMed

Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children. Genet Test Mol Biomarkers. 2012 May; 16(5):376-82.
View in: PubMed

A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):915-24.
View in: PubMed

Predictors of the first onset of a major depressive episode and changes in depressive symptoms across adolescence: stress and negative cognitions. J Abnorm Psychol. 2011 Nov; 120(4):779-96.
View in: PubMed

Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. J Clin Oncol. 2011 Nov 10; 29(32):4224-6.
View in: PubMed

Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One. 2011; 6(9):e23379.
View in: PubMed

Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer. 2011 Sep; 10(3):549-56.
View in: PubMed

Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res. 2011 Sep 01; 71(17):5792-805.
View in: PubMed

Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med. 2011 Jul; 13(7):651-7.
View in: PubMed

Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer Epidemiol Biomarkers Prev. 2011 Aug; 20(8):1690-702.
View in: PubMed

Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3-A randomized, placebo-controlled clinical trial. J Clin Oncol. 2011 Jun 20; 29(18_suppl):LBA504.
View in: PubMed

Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 2011 Jun 23; 364(25):2381-91.
View in: PubMed

PALB2 mutations in familial breast and pancreatic cancer. Fam Cancer. 2011 Jun; 10(2):225-31.
View in: PubMed

Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers. Cancer Discov. 2011 Jun; 1(1):29-34.
View in: PubMed

TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. J Clin Oncol. 2011 May 20; 29(15_suppl):1025.
View in: PubMed

Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer? J Clin Oncol. 2011 May 20; 29(15_suppl):1501.
View in: PubMed

Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3-A randomized, placebo-controlled clinical trial. J Clin Oncol. 2011 May 20; 29(15_suppl):LBA504.
View in: PubMed

Breast cancer phenotype in women with TP53 germ-line mutations: An LFS consortium effort. J Clin Oncol. 2011 May 20; 29(15_suppl):1519.
View in: PubMed

Prevalence of hereditary GIST susceptibility in adults with GIST. J Clin Oncol. 2011 May 20; 29(15_suppl):10043.
View in: PubMed

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet. 2011 Nov; 130(5):685-99.
View in: PubMed

Family cancer history: healthy skepticism required. J Natl Cancer Inst. 2011 May 18; 103(10):776-7.
View in: PubMed

Structure and measurement of depression in youths: applying item response theory to clinical data. Psychol Assess. 2011 Dec; 23(4):819-33.
View in: PubMed

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011 Apr; 13(4):349-55.
View in: PubMed

Attentional bias to pain and social threat in pediatric patients with functional abdominal pain and pain-free youth before and after performance evaluation. Pain. 2011 May; 152(5):1061-1067.
View in: PubMed

Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry. 2011 Jun; 168(6):593-602.
View in: PubMed

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):1032-8.
View in: PubMed

Targeting the missing links for cancer therapy. Nat Med. 2011 Mar; 17(3):283-4.
View in: PubMed

Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011 Feb; 13(1):67-75.
View in: PubMed

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers. Cancer. 2011 Jul 15; 117(14):3093-100.
View in: PubMed

Time to think outside the (genetic) box. Cancer Prev Res (Phila). 2011 Jan; 4(1):6-8.
View in: PubMed

Remission of depression in parents: links to healthy functioning in their children. Child Dev. 2011 Jan-Feb; 82(1):226-43.
View in: PubMed

Comorbidity of Anxiety and Depression in Youth: Implications for Treatment and Prevention. Clin Psychol (New York). 2010 Dec; 17(4):293-306.
View in: PubMed

DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res. 2010 Dec 01; 16(23):5796-804.
View in: PubMed

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 2010; 12(6):R95.
View in: PubMed

Intergenerational transmission of depression: a launch and grow model of change across adolescence. Dev Psychopathol. 2010 Nov; 22(4):819-30.
View in: PubMed

Dynamic associations between maternal depressive symptoms and adolescents' depressive and externalizing symptoms. J Abnorm Child Psychol. 2010 Nov; 38(8):1069-81.
View in: PubMed

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet. 2010 Oct 28; 6(10):e1001183.
View in: PubMed

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet. 2011 Jan; 48(1):64-8.
View in: PubMed

Breast cancer risk reduction. J Natl Compr Canc Netw. 2010 Oct; 8(10):1112-46.
View in: PubMed

Does neoadjuvant bevacizumab increase surgical complications in breast surgery? Ann Surg Oncol. 2011 Mar; 18(3):733-7.
View in: PubMed

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet. 2010 Oct; 42(10):885-92.
View in: PubMed

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010 Sep 01; 304(9):967-75.
View in: PubMed

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010 Sep-Oct; 17(5):908-16.
View in: PubMed

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 2010 Jul 24; 376(9737):235-44.
View in: PubMed

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. J Natl Cancer Inst. 2010 Jul 07; 102(13):942-9.
View in: PubMed

A prospective study of stress autonomy versus stress sensitization in adolescents at varied risk for depression. J Abnorm Psychol. 2010 May; 119(2):341-54.
View in: PubMed

Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010 May; 8(5):562-94.
View in: PubMed

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat. 2010 Jun; 121(2):389-98.
View in: PubMed

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol. 2010 Oct; 21(10):2107-2111.
View in: PubMed

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res Treat. 2010 Nov; 124(2):441-51.
View in: PubMed

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Breast Cancer Res Treat. 2010 Nov; 124(1):195-203.
View in: PubMed

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 2010; 12(1):R12.
View in: PubMed

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol. 2010 Mar 01; 28(7):1145-53.
View in: PubMed

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(1):137-44.
View in: PubMed

The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol. 2010 Jan; 220(1):17-23.
View in: PubMed

Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47.
View in: PubMed

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009 Nov; 7(10):1060-96.
View in: PubMed

The temporal relation between depression and comorbid psychopathology in adolescents at varied risk for depression. J Child Psychol Psychiatry. 2010 Mar; 51(3):242-9.
View in: PubMed

Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side. J Clin Oncol. 2009 Dec 10; 27(35):5862-4.
View in: PubMed

Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin. Mol Cancer Res. 2009 Sep; 7(9):1510-6.
View in: PubMed

PARP inhibition in breast cancer. Clin Adv Hematol Oncol. 2009 Sep; 7(9):573-5.
View in: PubMed

Genetic testing in young women with breast cancer: results from a Web-based survey. Ann Oncol. 2010 Apr; 21(4):741-747.
View in: PubMed

Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del. Cancer Res. 2009 Sep 01; 69(17):7030-7.
View in: PubMed

Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009 Sep 01; 69(17):7053-61.
View in: PubMed

Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer. Gynecol Oncol. 2009 Oct; 115(1):108-111.
View in: PubMed

Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together. Patient Educ Couns. 2010 Jan; 78(1):29-33.
View in: PubMed

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res. 2009 Jul 15; 69(14):5801-10.
View in: PubMed

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol. 2009 Jul; 33(7):1093-7.
View in: PubMed

Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer. J Clin Oncol. 2009 Jun 20; 27(18_suppl):CRA501.
View in: PubMed

Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009 Jun 03; 301(21):2215-24.
View in: PubMed

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009 Jul 01; 27(19):3235-58.
View in: PubMed

Determination of factors predicting for estrogen receptor positive (ER+) breast cancers in BRCA1 mutation carriers. J Clin Oncol. 2009 May 20; 27(15_suppl):11045.
View in: PubMed

Prevalence of CDH1 germline mutations in subjects with early onset or familial lobular breast cancer, a multicenter collaboration. J Clin Oncol. 2009 May 20; 27(15_suppl):11042.
View in: PubMed

Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy. J Clin Oncol. 2009 May 20; 27(15_suppl):551.
View in: PubMed

Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer. J Clin Oncol. 2009 May 20; 27(15_suppl):CRA501.
View in: PubMed

Parental decisions and outcomes regarding disclosing maternal BRCA1 and 2 test results to children. J Clin Oncol. 2009 May 20; 27(15_suppl):9582.
View in: PubMed

Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization. J Gen Intern Med. 2009 Jul; 24(7):822-8.
View in: PubMed

Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2009 May; 18(5):1379-85.
View in: PubMed

BRCA1/2-associated and sporadic breast cancers: fellow travelers or not? Cancer Prev Res (Phila). 2009 Feb; 2(2):100-3.
View in: PubMed

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res. 2009; 11(5):R76.
View in: PubMed

American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. 2009 Feb 20; 27(6):986-93.
View in: PubMed

Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008 Dec 15; 14(24):8010-8.
View in: PubMed

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clin Cancer Res. 2008 Dec 01; 14(23):7871-7.
View in: PubMed

Physicians' experiences with BRCA1/2 testing in community settings. J Clin Oncol. 2008 Dec 10; 26(35):5789-96.
View in: PubMed

A prospective study of the cognitive-stress model of depressive symptoms in adolescents. J Abnorm Psychol. 2008 Nov; 117(4):719-34.
View in: PubMed

Familial cancer database online. Lancet Oncol. 2008 Oct; 9(10):925-6.
View in: PubMed

Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms. J Clin Child Adolesc Psychol. 2008 Oct; 37(4):714-24.
View in: PubMed

Children's Somatization Inventory: psychometric properties of the revised form (CSI-24). J Pediatr Psychol. 2009 May; 34(4):430-40.
View in: PubMed

Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment. J Youth Adolesc. 2008 Sep; 37(8):906-916.
View in: PubMed

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations. Gynecol Oncol. 2008 Nov; 111(2):226-32.
View in: PubMed

Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psychooncology. 2008 Aug; 17(8):831-43.
View in: PubMed

Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer. 2008 Jul 22; 99(2):371-4.
View in: PubMed

Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry. 2008 Sep; 165(9):1136-47.
View in: PubMed

Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):536.
View in: PubMed

Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). J Pediatr Psychol. 2009 Jul; 34(6):627-38.
View in: PubMed

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA. 2008 Mar 19; 299(11):1315-9.
View in: PubMed

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol. 2008 May; 109(2):168-73.
View in: PubMed

Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4340-5.
View in: PubMed

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol. 2008 Mar 10; 26(8):1331-7.
View in: PubMed

Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol. 2008 Feb 10; 26(5):806-13.
View in: PubMed

Convergence among multiple methods of measuring positivity and negativity in the family environment: relation to depression in mothers and their children. J Fam Psychol. 2008 Feb; 22(1):123-34.
View in: PubMed

Time to check CHEK2 in families with breast cancer? J Clin Oncol. 2008 Feb 01; 26(4):519-20.
View in: PubMed

Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer. 2008; 7(1):73-82.
View in: PubMed

RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res. 2008 Jan 01; 68(1):22-5.
View in: PubMed

Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer. 2007 Dec 15; 121(12):2661-7.
View in: PubMed

Current and past maternal depression, maternal interaction behaviors, and children's externalizing and internalizing symptoms. J Abnorm Child Psychol. 2008 May; 36(4):527-37.
View in: PubMed

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer. 2007 Dec; 7(11):875-82.
View in: PubMed

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol. 2007 Nov 01; 96(6):474-80.
View in: PubMed

A typology of pain coping strategies in pediatric patients with chronic abdominal pain. Pain. 2008 Jul 15; 137(2):266-275.
View in: PubMed

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet. 2007 Dec; 81(6):1186-200.
View in: PubMed

Remission of maternal depression and child symptoms among single mothers: a STAR*D-Child report. Soc Psychiatry Psychiatr Epidemiol. 2007 Dec; 42(12):962-71.
View in: PubMed

Prevention of depressive symptoms in adolescents: a randomized trial of cognitive-behavioral and interpersonal prevention programs. J Consult Clin Psychol. 2007 Oct; 75(5):693-706.
View in: PubMed

Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use. Ann Surg Oncol. 2007 Dec; 14(12):3352-8.
View in: PubMed

Breast cancer risk reduction. J Natl Compr Canc Netw. 2007 Sep; 5(8):676-701.
View in: PubMed

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007 Sep 01; 25(25):3985-90.
View in: PubMed

Evidence-based assessment in pediatric psychology: measures of psychosocial adjustment and psychopathology. J Pediatr Psychol. 2008 Oct; 33(9):958-80; discussion 981-2.
View in: PubMed

Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007 Nov; 44(11):726-31.
View in: PubMed

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1416-21.
View in: PubMed

Prospective relations between organized activity participation and psychopathology during adolescence. J Abnorm Child Psychol. 2007 Dec; 35(6):1021-33.
View in: PubMed

Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clin Breast Cancer. 2007 Jun; 7(8):627-33.
View in: PubMed

Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007 Mar; 11(3):259-73.
View in: PubMed

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2007 Oct; 105(2):221-8.
View in: PubMed

Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test. 2007; 11(3):249-55.
View in: PubMed

Predicting school dropout and adolescent sexual behavior in offspring of depressed and nondepressed mothers. J Am Acad Child Adolesc Psychiatry. 2007 Jan; 46(1):15-24.
View in: PubMed

A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007 Jan; 211(1):26-35.
View in: PubMed

Ethical issues in cancer genetics: I 1) whose information is it? J Genet Couns. 2006 Dec; 15(6):491-503.
View in: PubMed

Depression in children and adolescents: linking risk research and prevention. Am J Prev Med. 2006 Dec; 31(6 Suppl 1):S104-25.
View in: PubMed

Modeling relations between hassles and internalizing and externalizing symptoms in adolescents: a four-year prospective study. J Abnorm Psychol. 2006 Aug; 115(3):428-42.
View in: PubMed

Validation of a symptom provocation test for laboratory studies of abdominal pain and discomfort in children and adolescents. J Pediatr Psychol. 2006 Aug; 31(7):703-13.
View in: PubMed

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst. 2006 Jul 05; 98(13):904-10.
View in: PubMed

The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg. 2006 Jul; 192(1):58-62.
View in: PubMed

Prevalence of BRCA1 mutations in triple negative breast cancer (BC). J Clin Oncol. 2006 Jun 20; 24(18_suppl):508.
View in: PubMed

Histopathological features of breast cancers in women with germline TP53 mutations. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10031.
View in: PubMed

Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons. Clin Breast Cancer. 2006 Jun; 7(2):158-61.
View in: PubMed

Trajectories of symptoms and impairment for pediatric patients with functional abdominal pain: a 5-year longitudinal study. J Am Acad Child Adolesc Psychiatry. 2006 Jun; 45(6):737-744.
View in: PubMed

The prevention of depressive symptoms in children and adolescents: A meta-analytic review. J Consult Clin Psychol. 2006 Jun; 74(3):401-15.
View in: PubMed

Appraisal and coping with daily stressors by pediatric patients with chronic abdominal pain. J Pediatr Psychol. 2007 Mar; 32(2):206-16.
View in: PubMed

The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. J Clin Oncol. 2006 Jun 20; 24(18):2948-57.
View in: PubMed

Breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2006 May; 4(5):480-508.
View in: PubMed

The PRIME curriculum. Clinical research training during residency. J Gen Intern Med. 2006 May; 21(5):506-9.
View in: PubMed

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol. 2006 Jun 01; 24(16):2437-43.
View in: PubMed

Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Cancer Res. 2006 Apr 01; 66(7):3452-5.
View in: PubMed

Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA. 2006 Mar 22; 295(12):1389-98.
View in: PubMed

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006; 8(2):R15.
View in: PubMed

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol. 2006 Mar; 7(3):223-9.
View in: PubMed

Parent attention versus distraction: impact on symptom complaints by children with and without chronic functional abdominal pain. Pain. 2006 May; 122(1-2):43-52.
View in: PubMed

Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2006 Feb; 4(2):156-76.
View in: PubMed

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006 Feb 01; 24(4):700-6.
View in: PubMed

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006 Feb; 30(2):230-6.
View in: PubMed

Children of currently depressed mothers: a STAR*D ancillary study. J Clin Psychiatry. 2006 Jan; 67(1):126-36.
View in: PubMed

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology. 2006 Jan; 130(1):73-9.
View in: PubMed

Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):70-5.
View in: PubMed

Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol. 2005 Dec 01; 23(34):8613-9.
View in: PubMed

The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 2006 Mar; 27(3):599-605.
View in: PubMed

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys. 2006 Feb 01; 64(2):496-504.
View in: PubMed

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2005 Nov 01; 23(31):7804-10.
View in: PubMed

Quality or quantity in the management of hereditary ovarian cancer risk: Is it really a trade-off? J Clin Oncol. 2005 Oct 01; 23(28):6817-9.
View in: PubMed

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control. 2005 Aug; 16(6):667-74.
View in: PubMed

The role of social stressors and interpersonal orientation in explaining the longitudinal relation between externalizing and depressive symptoms. J Abnorm Psychol. 2005 Aug; 114(3):432-43.
View in: PubMed

Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon? Breast Cancer Res Treat. 2005 Aug; 92(3):273-7.
View in: PubMed

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 2005 Jul; 1(1):72-80.
View in: PubMed

Testing a model of pain appraisal and coping in children with chronic abdominal pain. Health Psychol. 2005 Jul; 24(4):364-74.
View in: PubMed

Germline TP53 mutations in women with very early onset breast cancer (BR). J Clin Oncol. 2005 Jun; 23(16_suppl):1015.
View in: PubMed

Factor V Leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen. J Clin Oncol. 2005 Jun; 23(16_suppl):508.
View in: PubMed

Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1082-9.
View in: PubMed

Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred. J Clin Oncol. 2005 Apr 20; 23(12):2735-43.
View in: PubMed

The relations among maternal depression, maternal criticism, and adolescents' externalizing and internalizing symptoms. J Abnorm Child Psychol. 2005 Feb; 33(1):1-11.
View in: PubMed

Hereditary cancer predisposition syndromes. J Clin Oncol. 2005 Jan 10; 23(2):276-92.
View in: PubMed

Resting frontal brain activity: linkages to maternal depression and socio-economic status among adolescents. Biol Psychol. 2004 Oct; 67(1-2):77-102.
View in: PubMed

Cancer prevention and the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 01; 22(19):3848-51.
View in: PubMed

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2004 Jul 21; 96(14):1094-8.
View in: PubMed

A randomized trial of two different genetic counseling interventions for BRCA1/2 genetic testing. J Clin Oncol. 2004 Jul 15; 22(14_suppl):1002.
View in: PubMed

A feasibility study of tamoxifen chemoprevention in Hodgkin's disease (HD) survivors. J Clin Oncol. 2004 Jul 15; 22(14_suppl):8551.
View in: PubMed

Communication of BRCA1/2 test results to first-degree relatives (FDRs): Factors predicting who women tell. J Clin Oncol. 2004 Jul 15; 22(14_suppl):1010.
View in: PubMed

P27 and pAKT Expression in BRCA1-associated and sporadic breast tumors. J Clin Oncol. 2004 Jul 15; 22(14_suppl):9609.
View in: PubMed

Comparison of complementary medicine use at genetic testing program enrollment and one-year following results disclosure. J Clin Oncol. 2004 Jul 15; 22(14_suppl):1013.
View in: PubMed

The relations among depression in fathers, children's psychopathology, and father-child conflict: a meta-analysis. Clin Psychol Rev. 2004 Jul; 24(3):339-60.
View in: PubMed

Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet. 2004 Apr; 41(4):e44.
View in: PubMed

Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology. 2004 Mar; 126(3):936-7.
View in: PubMed

Prophylactic oophorectomy and hormone replacement therapy: protection at what price? J Clin Oncol. 2004 Mar 15; 22(6):978-80.
View in: PubMed

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004 Mar 15; 22(6):1055-62.
View in: PubMed

One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst. 2004 Jan 07; 96(1):2-3.
View in: PubMed

Accuracy of cancer family histories: comparison of two breast cancer syndromes. Genet Test. 2004; 8(3):222-8.
View in: PubMed

Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer. 2004; 3(1):1-10.
View in: PubMed

Progress in the management of gynecologic cancer: consensus summary statement. J Clin Oncol. 2003 May 15; 21(10 Suppl):129s-132s.
View in: PubMed

Relation of intelligence and religiosity to depressive disorders in offspring of depressed and nondepressed mothers. J Am Acad Child Adolesc Psychiatry. 2003 May; 42(5):578-86.
View in: PubMed

Breast cancer screening: a final analysis? CA Cancer J Clin. 2003 May-Jun; 53(3):138-40.
View in: PubMed

Cancer surveillance is often inadequate in people at high risk for colorectal cancer. J Med Genet. 2003 May; 40(5):e54.
View in: PubMed

Male patients with diagnoses of both breast cancer and prostate cancer. Breast J. 2003 May-Jun; 9(3):208-12.
View in: PubMed

Complementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev. 2003 Apr; 12(4):321-6.
View in: PubMed

Mothers depression in early childhood increases the risk of adolescent anxiety and depression. Evid Based Ment Health. 2003 Feb; 6(1):15.
View in: PubMed

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2002 Dec 04; 94(23):1773-9.
View in: PubMed

Social consequences of children's pain: when do they encourage symptom maintenance? J Pediatr Psychol. 2002 Dec; 27(8):689-98.
View in: PubMed

BRCA1/2 genetic testing in the community setting. J Clin Oncol. 2002 Nov 15; 20(22):4485-92.
View in: PubMed

Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002 Sep 15; 20(18 Suppl):34S-8S.
View in: PubMed

A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing. Genet Med. 2002 Sep-Oct; 4(5):346-52.
View in: PubMed

A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 2002 Jul 15; 62(14):3925-8.
View in: PubMed

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res. 2002 Jun 15; 62(12):3485-92.
View in: PubMed

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst. 2002 Jun 05; 94(11):844-51.
View in: PubMed

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002 Jun 01; 20(11):2701-12.
View in: PubMed

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002 May 23; 346(21):1616-22.
View in: PubMed

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. J Clin Oncol. 2002 Apr 15; 20(8):2085-91.
View in: PubMed

Depressive spectrum disorders in high-risk adolescents: episode duration and predictors of time to recovery. J Am Acad Child Adolesc Psychiatry. 2002 Apr; 41(4):410-8.
View in: PubMed

Developmental trajectories of adolescents' depressive symptoms: predictors of change. J Consult Clin Psychol. 2002 Feb; 70(1):79-95.
View in: PubMed

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res. 2001 Nov 15; 61(22):8062-7.
View in: PubMed

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 2001 Oct; 11(7):635-8.
View in: PubMed

Genetic susceptibility for breast cancer--risk assessment and counseling. Semin Oncol. 2001 Aug; 28(4):419-33.
View in: PubMed

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res. 2001 Jul 15; 61(14):5420-4.
View in: PubMed

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet. 2001 May 12; 357(9267):1467-70.
View in: PubMed

Ukrainian application of the Children's Somatization Inventory: psychometric properties and associations with internalizing symptoms. J Abnorm Child Psychol. 2001 Apr; 29(2):165-75.
View in: PubMed

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev. 2001 Feb; 10(2):83-7.
View in: PubMed

The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol. 2001 Feb; 69(1):85-91.
View in: PubMed

Commentary on Eccles et al.: familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer. 2001; 1(2):73-4.
View in: PubMed

Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res. 2000 Dec 15; 60(24):6859-63.
View in: PubMed

Disclosure of familial genetic information: perceptions of the duty to inform. Am J Med. 2000 Dec 15; 109(9):705-11.
View in: PubMed

Laboratory and performance-based measures of depression in children and adolescents. J Clin Child Psychol. 2000 Dec; 29(4):509-25.
View in: PubMed

Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol. 2000 Dec; 27(6):712-26.
View in: PubMed

Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000 Oct 01; 18(19):3360-9.
View in: PubMed

Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet. 2000 Sep; 37(9):641-5.
View in: PubMed

Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA. 2000 Aug 16; 284(7):857-60.
View in: PubMed

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol. 2000 Jul; 18(14):2728-32.
View in: PubMed

An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer. 2000 Jul; 28(3):300-7.
View in: PubMed

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol. 2000 May; 18(10):2135-42.
View in: PubMed

Children's perceptions of peers with somatic symptoms: the impact of gender, stress, and illness. J Pediatr Psychol. 2000 Apr-May; 25(3):125-35.
View in: PubMed

Psychosocial antecedents of variation in girls' pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev. 2000 Mar-Apr; 71(2):485-501.
View in: PubMed

Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol. 2000 Mar; 18(6):1212-9.
View in: PubMed

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA. 2000 Feb 02; 283(5):617-24.
View in: PubMed

Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int. 2000 Feb; 66(2):100-3.
View in: PubMed

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes Cancer. 2000 Feb; 27(2):124-9.
View in: PubMed

Behavioral risk factors among women presenting for genetic testing. Cancer Epidemiol Biomarkers Prev. 2000 Jan; 9(1):89-94.
View in: PubMed

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 1999 Dec 24; 286(5449):2528-31.
View in: PubMed

Case Report-Loyalty, Legacy, and Ledger: Contextual Therapy in a Patient with a Family History of Ovarian Cancer. J Genet Couns. 1999 Dec; 8(6):359-72.
View in: PubMed

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999 Nov 27; 354(9193):1846-50.
View in: PubMed

A 40-year-old woman with a strong family history of breast cancer. JAMA. 1999 Nov 24; 282(20):1953-60.
View in: PubMed

Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 1999 Oct 15; 59(20):5068-74.
View in: PubMed

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst. 1999 Sep 01; 91(17):1475-9.
View in: PubMed

Privacy in genetics research. Science. 1999 Aug 27; 285(5432):1359-61.
View in: PubMed

Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA. 1999 Jul 21; 282(3):247-53.
View in: PubMed

p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Oncogene. 1999 Jul 08; 18(27):3970-8.
View in: PubMed

The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psychooncology. 1999 May-Jun; 8(3):220-9.
View in: PubMed

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet. 1999 May; 64(5):1371-7.
View in: PubMed

Alternative intrathecal agents for the treatment of pain. Neuromodulation. 1999 Apr; 2(2):85-91.
View in: PubMed

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15; 129(10):787-96.
View in: PubMed

Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. Calcif Tissue Int. 1998 Nov; 63(5):363-8.
View in: PubMed

Concordance between mothers' and children's reports of somatic and emotional symptoms in patients with recurrent abdominal pain or emotional disorders. J Abnorm Child Psychol. 1998 Oct; 26(5):381-91.
View in: PubMed

Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene. 1998 Aug 13; 17(6):727-31.
View in: PubMed

Family predictors of suicidal symptoms in young adolescents. J Adolesc. 1998 Aug; 21(4):445-57.
View in: PubMed

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998 Jul; 16(7):2417-25.
View in: PubMed

Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J Clin Endocrinol Metab. 1998 Jul; 83(7):2324-30.
View in: PubMed

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet. 1998 Jun; 62(6):1381-8.
View in: PubMed

Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1998 Jun; 16(6):2045-51.
View in: PubMed

Genetic testing for susceptibility to cancer. Task Force on Cancer Genetics Education. JAMA. 1998 May 27; 279(20):1612-3.
View in: PubMed

Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst. 1998 May 20; 90(10):761-6.
View in: PubMed

Inherited breast cancer: increasingly familiar territory. J Clin Oncol. 1998 May; 16(5):1639-41.
View in: PubMed

Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998 Apr 15; 90(8):606-11.
View in: PubMed

Carcinoembryonic antigen in breast nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev. 1998 Mar; 7(3):195-8.
View in: PubMed

The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med. 1998; 20(1):7-12.
View in: PubMed

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol. 1998 Jan; 16(1):133-8.
View in: PubMed

The effect of PTH antagonist BIM-44002 on serum calcium and PTH levels in hypercalcemic hyperparathyroid patients. Calcif Tissue Int. 1997 Dec; 61(6):455-9.
View in: PubMed

The American Society of Clinical Oncology position on genetic testing: implications for health care providers: workshop no. 4. Cancer. 1997 Aug 01; 80(3 Suppl):632-4.
View in: PubMed

Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. J Womens Health. 1997 Jun; 6(3):349-51.
View in: PubMed

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997 May 15; 336(20):1465-71.
View in: PubMed

Diagnosis in Oncology. Leukemia cutis. J Clin Oncol. 1997 May; 15(5):2170-1.
View in: PubMed

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 26; 277(12):997-1003.
View in: PubMed

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 19; 277(11):915-9.
View in: PubMed

Defining etiologic heterogeneity in breast cancer using genetic biomarkers. Prog Clin Biol Res. 1997; 396:53-61.
View in: PubMed

Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 1996 Nov 07; 335(19):1413-6.
View in: PubMed

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996 Nov; 2(11):1179-83.
View in: PubMed

Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet. 1996 Sep; 59(3):547-53.
View in: PubMed

"First do no harm" also applies to cancer susceptibility testing. Cancer J Sci Am. 1996 Sep-Oct; 2(5):250-2.
View in: PubMed

Testing for inherited cancer susceptibility. JAMA. 1996 Jun 26; 275(24):1928-9.
View in: PubMed

Prostate-specific antigen in nipple aspirate. Lancet. 1996 Jun 08; 347(9015):1631.
View in: PubMed

Display rules for anger, sadness, and pain: it depends on who is watching. Child Dev. 1996 Jun; 67(3):957-73.
View in: PubMed

BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet. 1996 May; 13(1):123-5.
View in: PubMed

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996 Jan 18; 334(3):143-9.
View in: PubMed

A test of the cognitive diathesis-stress model of depression in children: academic stressors, attributional style, perceived competence, and control. J Pers Soc Psychol. 1995 Aug; 69(2):370-80.
View in: PubMed

Cognitions and stress: direct and moderating effects on depressive versus externalizing symptoms during the junior high school transition. J Abnorm Psychol. 1995 Aug; 104(3):453-63.
View in: PubMed

Commentary: recurrent abdominal pain. J Pediatr Psychol. 1995 Aug; 20(4):407-11.
View in: PubMed

Do parents excuse the misbehavior of children with physical or emotional symptoms? An investigation of the pediatric sick role. J Pediatr Psychol. 1995 Jun; 20(3):329-45.
View in: PubMed

Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Cancer Res. 1995 May; 1(5):539-44.
View in: PubMed

Testing for cancer genes: decisions, decisions. Nat Med. 1995 Apr; 1(4):302-3.
View in: PubMed

Long-term health outcomes in patients with recurrent abdominal pain. J Pediatr Psychol. 1995 Apr; 20(2):233-45.
View in: PubMed

Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet. 1995 Mar; 56(3):608-15.
View in: PubMed

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 1995 Feb 15; 273(7):577-85.
View in: PubMed

Ethical, social and counselling issues in hereditary cancer susceptibility. Cancer Surv. 1995; 25:381-97.
View in: PubMed

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995 Jan; 56(1):254-64.
View in: PubMed

Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations. J Natl Cancer Inst Monogr. 1995; (17):9-14.
View in: PubMed

Testing and counseling adults for heritable cancer risk. J Natl Cancer Inst Monogr. 1995; (17):115-8.
View in: PubMed

Somatic complaints in pediatric patients: a prospective study of the role of negative life events, child social and academic competence, and parental somatic symptoms. J Consult Clin Psychol. 1994 Dec; 62(6):1213-21.
View in: PubMed

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet. 1994 Dec; 8(4):387-91.
View in: PubMed

Markers of risk for human malignancies. Hematol Oncol Clin North Am. 1994 Jun; 8(3):471-83.
View in: PubMed

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1994 Apr 08; 77(1):1 p following 166.
View in: PubMed

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993 Dec 03; 75(5):1027-38.
View in: PubMed

Screening children at genetic risk of cancer. Curr Opin Pediatr. 1993 Dec; 5(6):712-5.
View in: PubMed

Family history and breast cancer. Probabilities and possibilities. JAMA. 1993 Oct 06; 270(13):1602-3.
View in: PubMed

Psychosocial correlates of recurrent childhood pain: a comparison of pediatric patients with recurrent abdominal pain, organic illness, and psychiatric disorders. J Abnorm Psychol. 1993 May; 102(2):248-58.
View in: PubMed

Gene for familial breast and ovarian cancer. Lancet. 1993 Apr 24; 341(8852):1060-1.
View in: PubMed

Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA. 1993 Apr 21; 269(15):1970-4.
View in: PubMed

Cognitions, depressive symptoms, and development in adolescents. J Abnorm Psychol. 1993 Feb; 102(1):47-57.
View in: PubMed

Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992 Aug 05; 84(15):1156-60.
View in: PubMed

Screening for germ line TP53 mutations in breast cancer patients. Cancer Res. 1992 Jun 01; 52(11):3234-6.
View in: PubMed

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14; 326(20):1309-15.
View in: PubMed

Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res. 1991 Nov 15; 51(22):6094-7.
View in: PubMed

Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms. Lancet. 1991 Oct 26; 338(8774):1079-80.
View in: PubMed

Somatization symptoms in pediatric abdominal pain patients: relation to chronicity of abdominal pain and parent somatization. J Abnorm Child Psychol. 1991 Aug; 19(4):379-94.
View in: PubMed

What can specificity designs say about causality in psychopathology research? Psychol Bull. 1991 Jul; 110(1):129-36.
View in: PubMed

Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor. J Clin Endocrinol Metab. 1991 Jul; 73(1):99-106.
View in: PubMed

Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer. 1990 Dec 15; 66(12):2658-60.
View in: PubMed

Melanoma and soft tissue sarcoma in seven patients. Cancer. 1990 Dec 01; 66(11):2432-4.
View in: PubMed

Comprehensive management of disseminated breast cancer. Cancer. 1990 Sep 15; 66(6 Suppl):1439-48.
View in: PubMed

Recurrent abdominal pain in children: psychiatric diagnoses and parental psychopathology. J Am Acad Child Adolesc Psychiatry. 1990 Jul; 29(4):648-56.
View in: PubMed

Improving first appointment attendance rates in child psychiatry outpatient clinics. J Am Acad Child Adolesc Psychiatry. 1990 Jul; 29(4):657-60.
View in: PubMed

Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 1990 May 01; 65(9 Suppl):2132-47.
View in: PubMed

The value of studying cancer families. J Clin Oncol. 1990 Apr; 8(4):574-5.
View in: PubMed

Follow-up of cancer family with in-vitro radioresistance. Lancet. 1990 Jan 20; 335(8682):176-7.
View in: PubMed

The use of chemotherapy in metastatic breast cancer. Hematol Oncol Clin North Am. 1989 Dec; 3(4):807-21.
View in: PubMed

Long-term follow-up of children exposed in utero to antineoplastic agents. Semin Oncol. 1989 Oct; 16(5):437-44.
View in: PubMed

Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst. 1988 Dec 21; 80(20):1626-8.
View in: PubMed

Epithelioid sarcoma with diffuse bone marrow metastases and associated leukemoid reaction. A case report and brief literature review. Am J Clin Pathol. 1988 Dec; 90(6):723-6.
View in: PubMed

Recurrent depression in adolescents: a follow-up study. J Am Acad Child Adolesc Psychiatry. 1988 Jan; 27(1):49-54.
View in: PubMed

Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5404-8.
View in: PubMed

Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987 Jul; 1(2):105-11.
View in: PubMed

AIDS and self-organization among intravenous drug users. Int J Addict. 1987 Mar; 22(3):201-19.
View in: PubMed

Ectopic bone formation in children and adolescents with head injuries: its management. J Pediatr Orthop. 1987 Jan-Feb; 7(1):83-90.
View in: PubMed

A stage model of HTLV-III LAV infection in intravenous drug users. NIDA Res Monogr. 1986; 67:328-34.
View in: PubMed

Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med. 1984 Aug 16; 311(7):467-8.
View in: PubMed

Waldenström's macroglobulinemia and autoimmune disease in a family. Ann Intern Med. 1980 Dec; 93(6):830-2.
View in: PubMed

Universal versus personal helplessness in depression: belief in uncontrollability or incompetence? J Abnorm Psychol. 1980 Feb; 89(1):56-66.
View in: PubMed

A simple method for splicing the common bile duct into the duodenum of the rat. Gastroenterology. 1954 Feb; 26(2):312-5.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street
Newton, MA 02459
Get Directions

Ratings

Top